Company
CEO Message
Corporate Profile
Management
History
Access
Business & Technology
Technology
Application to small molecule cancer drugs
Application to nucleic acid therapeutics
Application to cosmetics
Business Model
Gene therapy
Regenerative Medicine – Acti-PRP
Pipeline
Investor Relations
News Releases
Financial Highlights
IR Report
Stock Information
Stock Price
Analyst Coverage
JP
/ EN
We will contribute ourselves to
the health and well being of
people by creating new value.
What's New
News Releases
Clinical Pipeline
NC-6004
Cisplatin micelle
Head and Neck cancer
phaseⅠ
phaseⅡ
phaseⅢ
VB-111
(In-Licensed) Non-replicating Adeno 5 vectors
Ovarian cancer
phaseⅠ
phaseⅡ
phaseⅢ
Pipeline
Business for Drug Discovery
Technology
Business Model